GEN Exclusives

More »

Sidebars

More »
Mar 15, 2009 (Vol. 29, No. 6)

China Gains in Innovative R&D

  • In discussing why his company recently opened a 60,000 sq-ft preclinical facility in Shanghai, Chris Perkin, corporate senior vp and president of Canadian and Chinese preclinical services at Charles River Laboratories, notes that China is rapidly “evolving as a center of innovation in research and development.” In the past, China was mainly viewed as a country where low-cost pharmaceutical manufacturing could be carried out.

    Perkin says Charles River is providing its clients with services and support needed to accelerate their drug development programs in China.

    “Initially, what they need is discovery support through to the investigative new drug submission,” he explains. “We’ll be one of the first major Western CROs to open a Western-style GLP facility in China.”


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?